How the Fibrotic Lung Microenvironment Regulates Stem Cell Behavior: Immune Cues, Extracellular Matrix Remodeling, and Therapeutic Implications
Analytical Cellular Pathology · 2026
DOI: 10.1155/ancp/1319659 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Analytical Cellular Pathology, 2026. Verfasst von Zihan Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China, seu.edu.cn. Hauptthemen laut MEDLINE: Extracellular Matrix, Pulmonary Fibrosis, Stem Cells, Lung. Die Arbeit nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhongda Hospital - Lianyungang First People's Hospital Joint Fund.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) is a chronic and progressive interstitial lung disease characterized by excessive extracellular matrix (ECM) deposition and remodeling of lung structures. Currently, no effective clinical treatments exist to reverse or halt the progression of PF. Consequently, there is an urgent need to identify novel therapeutic strategies for this complex disease. Stem cells, renowned for their self‐renewal and multipotent differentiation capabilities, have garnered considerable attention for their potential therapeutic applications, particularly in regenerative medicine. The primary stem cell types investigated for PF treatment include mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and lung progenitor cells. Preclinical studies have demonstrated that these stem cells can reduce inflammation, modulate immune responses, and promote the repair of damaged lung tissue. Although stem cell transplantation shows promise in PF treatment, challenges such as safety, quality control, and therapeutic efficacy remain unresolved. Recent studies have highlighted that stem cells interact with and modify their transplanted environment, influencing their structural properties and chemical composition. These interactions strongly influence stem cell survival, phenotype, and therapeutic efficacy. Understanding these dynamics will inform the development of new strategies to improve the effectiveness of stem cell therapies for PF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China, seu.edu.cn.
- Department of Medicine, Southeast University, Nanjing, Jiangsu, China, seu.edu.cn.
- Department of Respiratory and Critical Care Medicine, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China, lygyy.com.cn.
ORCID-Profile: Jie Huang
Förderung
- National Natural Science Foundation of China
- Zhongda Hospital - Lianyungang First People's Hospital Joint Fund
Zitieren
APA
Zhou, Z., Han, S., Duan, Y., Hong, M., & Huang, J. (2026). How the Fibrotic Lung Microenvironment Regulates Stem Cell Behavior: Immune Cues, Extracellular Matrix Remodeling, and Therapeutic Implications. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/1319659
Vancouver
Zhou Z, Han S, Duan Y, Hong M, Huang J. How the Fibrotic Lung Microenvironment Regulates Stem Cell Behavior: Immune Cues, Extracellular Matrix Remodeling, and Therapeutic Implications. Analytical Cellular Pathology. 2026. doi:10.1155/ancp/1319659
BibTeX
@article{Zhou2026,
author = {Zhou, Zihan and Han, Shuhua and Duan, Yuanfang and Hong, Minqi and Huang, Jie},
title = {How the Fibrotic Lung Microenvironment Regulates Stem Cell Behavior: Immune Cues, Extracellular Matrix Remodeling, and Therapeutic Implications},
journal = {Analytical Cellular Pathology},
year = {2026},
doi = {10.1155/ancp/1319659}
}
EUVIMED